DE68914750D1 - Therapeutische Nucleoside. - Google Patents

Therapeutische Nucleoside.

Info

Publication number
DE68914750D1
DE68914750D1 DE68914750T DE68914750T DE68914750D1 DE 68914750 D1 DE68914750 D1 DE 68914750D1 DE 68914750 T DE68914750 T DE 68914750T DE 68914750 T DE68914750 T DE 68914750T DE 68914750 D1 DE68914750 D1 DE 68914750D1
Authority
DE
Germany
Prior art keywords
therapeutic nucleosides
nucleosides
therapeutic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE68914750T
Other languages
English (en)
Other versions
DE68914750T2 (de
Inventor
Saad George Rahim
Thomas Anthony Krenitsky
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB888819732A external-priority patent/GB8819732D0/en
Priority claimed from GB898901294A external-priority patent/GB8901294D0/en
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Application granted granted Critical
Publication of DE68914750D1 publication Critical patent/DE68914750D1/de
Publication of DE68914750T2 publication Critical patent/DE68914750T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06Pyrimidine radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
DE68914750T 1988-08-19 1989-08-18 Therapeutische Nucleoside. Expired - Lifetime DE68914750T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB888819732A GB8819732D0 (en) 1988-08-19 1988-08-19 Therapeutic nucleosides
GB898901294A GB8901294D0 (en) 1989-01-20 1989-01-20 Therapeutic nucleosides

Publications (2)

Publication Number Publication Date
DE68914750D1 true DE68914750D1 (de) 1994-05-26
DE68914750T2 DE68914750T2 (de) 1994-10-20

Family

ID=26294302

Family Applications (1)

Application Number Title Priority Date Filing Date
DE68914750T Expired - Lifetime DE68914750T2 (de) 1988-08-19 1989-08-18 Therapeutische Nucleoside.

Country Status (18)

Country Link
US (1) US5157114A (de)
EP (1) EP0356166B1 (de)
JP (1) JPH02108695A (de)
KR (1) KR900011468A (de)
AU (1) AU617210B2 (de)
CA (1) CA1336430C (de)
DE (1) DE68914750T2 (de)
DK (1) DK406689A (de)
ES (1) ES2052922T3 (de)
FI (1) FI893897A (de)
HU (1) HU204841B (de)
IE (1) IE892654L (de)
IL (1) IL91356A0 (de)
MX (1) MX9203420A (de)
MY (1) MY105855A (de)
NZ (1) NZ230356A (de)
PH (1) PH26733A (de)
PT (1) PT91489B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5215970A (en) * 1987-04-16 1993-06-01 Medivir Ab Nucleosides and nucleotide analogues, pharmaceutical composition and processes for the preparation of the compounds
US5506215A (en) * 1987-11-03 1996-04-09 Medivir Ab 1-(3'-fluoro-2',3'-dideoxy-β-D-ribofuranosyl)-5-substituted pyrimidine nucleosides
GB9012899D0 (en) * 1990-06-09 1990-08-01 Wellcome Found Anti-hbv pyrimidine nucleoside
GB9014618D0 (en) * 1990-06-30 1990-08-22 Wellcome Found Process for the preparation of pyrimidine nucleosides
GB9020930D0 (en) * 1990-09-26 1990-11-07 Wellcome Found Pharmaceutical combinations
GB9309787D0 (en) * 1993-05-12 1993-06-23 Rhone Poulenc Chemicals Purification of fluoronucleosides
DE69412090T2 (de) * 1993-05-12 1999-01-07 Rhodia Ltd Herstellung von fluoro-nukleosiden und dafür geeignete zwischenprodukte
GB9309795D0 (en) * 1993-05-12 1993-06-23 Rhone Poulenc Chemicals Preparation of flouro-compounds
JP3646651B2 (ja) * 1998-01-30 2005-05-11 ダイソー株式会社 ブタントリオール誘導体の製造法
MX2007006646A (es) 2004-12-03 2007-11-16 Adherex Technologies Inc Metodos para administrar inhibidores de dihidropirimidina deshidrogenasa en combinacion con 5-fluorouracilo y profarmacos de 5-fluorouracilo.
ES2644237T3 (es) 2009-10-14 2017-11-28 Elion Oncology Llc Tratamiento de neurotoxicidad asociada a combinaciones de 5-FU o sus profármacos e inhibidores de DPD

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1161586A (en) * 1968-01-15 1969-08-13 Deptsche Akademie Der Wissensc 5'-Desoxy-5'-Fluoro-Substituted 2'-Desoxy-Ribonucleosides
US3562250A (en) * 1968-07-30 1971-02-09 Akad Wissenschaften Ddr 2',5'-dideoxy-5'-fluoro nucleosides and process for preparing same
US3775397A (en) * 1969-11-12 1973-11-27 Akad Wissenschaften Ddr Novel cytostatic 2',3'-dideoxy-3'-fluoropyrimidine-nucleosides
US3928319A (en) * 1971-06-16 1975-12-23 Syntex Inc 4 -Fluoro nucleosides, novel intermediates and methods of preparing same
US4526988A (en) * 1983-03-10 1985-07-02 Eli Lilly And Company Difluoro antivirals and intermediate therefor
US4666892A (en) * 1984-03-06 1987-05-19 Sloan-Kettering Memorial Cancer Center Method and composition for hepatitis treatment with pyrimidine nucleoside compounds
GB8517402D0 (en) * 1985-07-10 1985-08-14 Wellcome Found Treatment of viral infections
SE8602981D0 (sv) * 1986-07-04 1986-07-04 Astra Laekemedel Ab Novel medicinal use
DD279407A1 (de) * 1986-07-24 1990-06-06 Akad Wissenschaften Ddr Verfahren zur herstellung eines mittels gegen aids
GB8629892D0 (en) * 1986-12-15 1987-01-28 Wellcome Found Antiviral compounds
EP0286825A3 (de) * 1987-03-18 1989-04-12 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Verwendung von 3'-fluro-3'-deoxythymidine zur Herstellung von medicamenten zur Behandlung von Viruskrankheiten
SE8701605D0 (sv) * 1987-04-16 1987-04-16 Astra Ab Novel medicinal compounds
JPS6422894A (en) * 1987-07-17 1989-01-25 Asahi Glass Co Ltd Nulceosides
JPS6426593A (en) * 1987-07-21 1989-01-27 Asahi Glass Co Ltd Nucleoside derivative
JPS6429393A (en) * 1987-07-24 1989-01-31 Asahi Glass Co Ltd Nucleoside analog
GB8719877D0 (en) * 1987-08-22 1987-09-30 Wellcome Found Antiviral compounds
SE8704298D0 (sv) * 1987-11-03 1987-11-03 Astra Ab Compounds for use in therapy
GB8726136D0 (en) * 1987-11-07 1987-12-09 Wellcome Found Therapeutic nucleosides
EP0316592A3 (de) * 1987-11-13 1990-09-19 Stichting REGA V.Z.W. 3'-Fluor-2',3'-dideoxyuridin und seine therapeutische Verwendung

Also Published As

Publication number Publication date
US5157114A (en) 1992-10-20
PH26733A (en) 1992-09-28
DK406689D0 (da) 1989-08-18
ES2052922T3 (es) 1994-07-16
EP0356166B1 (de) 1994-04-20
FI893897A (fi) 1990-02-20
IL91356A0 (en) 1990-03-19
AU617210B2 (en) 1991-11-21
IE892654L (en) 1990-02-19
EP0356166A3 (en) 1990-09-12
DE68914750T2 (de) 1994-10-20
HU204841B (en) 1992-02-28
EP0356166A2 (de) 1990-02-28
DK406689A (da) 1990-02-20
FI893897A0 (fi) 1989-08-18
MY105855A (en) 1995-02-28
AU4006189A (en) 1990-02-22
MX9203420A (es) 1992-07-01
JPH02108695A (ja) 1990-04-20
PT91489B (pt) 1995-05-04
CA1336430C (en) 1995-07-25
HUT51285A (en) 1990-04-28
NZ230356A (en) 1991-09-25
PT91489A (pt) 1990-03-08
KR900011468A (ko) 1990-08-01

Similar Documents

Publication Publication Date Title
ATE116648T1 (de) Therapeutische nucleoside.
NL960001I2 (nl) Therapeutische nucleosiden.
KR910002326A (ko) 치료용 뉴클레오시드
NL990028I2 (nl) Therapeutische nucleosiden.
DE3852710D1 (de) Therapeutische Nukleoside.
DK23489A (da) Nucleosidderivater
DK564088D0 (da) Nukleosidderivater
DE68914750D1 (de) Therapeutische Nucleoside.
DK626989A (da) Adenosinderivater
DE3872028T2 (de) Therapeutische nucleoside.
MX9203214A (es) Nucleosidos terapeuticos.
ATE104675T1 (de) Therapeutische nucleoside.
ATE77386T1 (de) Therapeutische nucleoside.
DK725088A (da) Terapeutiske nucleosider
NO911965D0 (no) Nukleosid-analoger.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee